Ajooni Biotech Receives Upgraded Credit Rating & Right Issue Details
May 03, 2024
Punjab [India], May 3: Ajooni Biotech Limited is thrilled to share that CRISIL Limited has raised company's long-term credit facilities ratings to "CRISIL BB+/ Stable". This upgrade underscores company's ongoing efforts to improve risk profile, revenue streams, and operational profitability. It highlights the significant expertise of company's promoters, strong customer partnerships, and favourable financial risk position. Although company recognize the potential impact of fluctuating raw material prices, they are fully committed to managing and minimizing such risks.